Camp4 director sells 10 CAMP shares at $4.50
Rhea-AI Filing Summary
Camp4 Therapeutics Corp (CAMP) director Andrew J. Schwab reported a small sale of 10 shares of common stock on 2026-08-24 at $4.50 per share. The shares are held indirectly through 5AM Ventures VI, L.P., with Schwab reporting shared voting and investment power through his role at its general partner and disclaiming beneficial ownership except for his pecuniary interest.
Following this transaction, entities associated with Schwab reported indirect holdings of 2,433,270 shares via 5AM Ventures VI, L.P., 2,941,176 shares via 5AM Ventures VII, L.P., and 302,770 shares via 5AM Opportunities II, L.P. The filing does not indicate use of a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 10 shares
Net Sell
3 txns
Insider
Schwab Andrew J.
Role
Director
Sold
10 shs ($45.00)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 10 | $4.50 | $45.00 |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,433,270 shares (Indirect, By 5AM Ventures VI, L.P.);
Common Stock — 2,941,176 shares (Indirect, By 5AM Ventures VII, L.P.);
Common Stock — 302,770 shares (Indirect, By 5AM Opportunities II, L.P.)
Footnotes (3)
- F1. The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. The Reporting Person is a managing member of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F2. The shares are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F3. The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. The Reporting Person is a managing member of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II GP. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Key Figures
Shares sold: 10 shares of Common Stock
Sale price per share: $4.5000 per share
Indirect holdings via 5AM Ventures VI, L.P.: 2,433,270 shares of Common Stock
+2 more
5 metrics
Shares sold
10 shares of Common Stock
Sale on 2026-08-24 reported by director Andrew J. Schwab
Sale price per share
$4.5000 per share
Price for the 10-share sale of Camp4 Therapeutics Corp common stock
Indirect holdings via 5AM Ventures VI, L.P.
2,433,270 shares of Common Stock
Total shares indirectly held after the reported transaction
Indirect holdings via 5AM Ventures VII, L.P.
2,941,176 shares of Common Stock
Holding entry as of 2026-08-24
Indirect holdings via 5AM Opportunities II, L.P.
302,770 shares of Common Stock
Holding entry as of 2026-08-24
Key Terms
indirect, beneficial ownership, pecuniary interest, shared voting and investment power
4 terms
indirect financial
"The transaction was reported as an indirect sale through 5AM Ventures VI, L.P."
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of such shares except"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of such shares except to the extent of his pecuniary interest"
FAQ
What insider transaction did CAMP director Andrew J. Schwab report on this Form 4?
Andrew J. Schwab reported a sale of 10 shares of Camp4 Therapeutics Corp common stock on 2026-08-24 at a price of $4.50 per share. The transaction was reported as an indirect sale through 5AM Ventures VI, L.P.
Was the August 24, 2026 CAMP stock sale under a Rule 10b5-1 trading plan?
No. The Form 4 for Camp4 Therapeutics Corp indicates the Rule 10b5-1 checkbox as not checked, and the footnotes do not describe the 10-share sale on 2026-08-24 as being made under a Rule 10b5-1 trading plan.
How is Andrew J. Schwab’s ownership in CAMP characterized in the Form 4 footnotes?
The footnotes state that shares are directly held by 5AM Ventures VI, VII, and Opportunities II, with Schwab as a managing member of their general partners. He may be deemed to share voting and investment power but disclaims beneficial ownership except for his pecuniary interest.
Is the reported CAMP stock transaction a direct or indirect holding for Andrew J. Schwab?
The reported 10-share sale of Camp4 Therapeutics Corp common stock is classified as an indirect transaction, with ownership noted as “By 5AM Ventures VI, L.P.” and Schwab’s role described through the general partner entity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
